Endosense Builds Further Validation for the TactiCath(R) with a Host of New Clinical Abstracts  
6/17/2010 8:18:20 AM

GENEVA--(BUSINESS WIRE)--Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced the unveiling of five new clinical abstracts on the use of contact force sensing in catheter ablation at Cardiostim 2010, June 16 – 19 in Nice, France. The abstracts, which feature the company’s TactiCath force-sensing ablation catheter, build on a growing body of research demonstrating the potential of contact force sensing to improve the safety and effectiveness of catheter ablation procedures.